Article Data

  • Views 961
  • Dowloads 118

Reviews

Open Access

Solitary splensolenic metastasis of endometrial carcinoma ten years after hysterectomy. Case report and review of the literature

  • C. Hadjileontis1,2
  • I. Amplianitis1
  • C. Valsamides3
  • G. Harisis3
  • H. Nepka1
  • A. Kafanas1,*,

1Pathology Department, Serres General Hospital, Greece

2Pathology Department, Medical School, Aristotle University of Thessaloniki, Greece

3Surgical Department A., General Hospital Serres, Greece

DOI: 10.12892/ejgo200402233 Vol.25,Issue 2,March 2004 pp.233-235

Published: 10 March 2004

*Corresponding Author(s): A. Kafanas E-mail:

Abstract

Solitary carcinomatous metastases to the spleen are rare. The reports of such cases in the literature usually concern late stages of the disease, with generalized carcinomatosis and metastatic foci in several other organs. Primary tumors that most often metastasize to the spleen are carcinomata of the breast, lung and ovaries, as well as malignant melanomata. Less often, carcinomata of the stomach, large bowel and kidneys are reported to implicate the organ with metastatic disease. The presence of solitary splenic metastasis of endometrial origin however, is extremely rare. We present a case of a 53-year-old female patient who ten years after hysterectomy due to the presence of endometrial carcinoma developed a metastatic focus to the spleen. This focus was diagnosed on the grounds of histology and immunohistochemistry, after splenic excision, to be of endometrial origin. Together with this case presentation, several aspects of the disease and its differential diagnosis are discussed, in correlation with the current literature.

Keywords

Endometrial carcinoma; Solitary splenic metastasis; Immunohistochemistry

Cite and Share

C. Hadjileontis,I. Amplianitis,C. Valsamides,G. Harisis,H. Nepka,A. Kafanas. Solitary splensolenic metastasis of endometrial carcinoma ten years after hysterectomy. Case report and review of the literature. European Journal of Gynaecological Oncology. 2004. 25(2);233-235.

References

[1] Arent P., Amuli M., Algada R., Blondiau J.V., Wauters G., Chamiec M. et al.: "Isolated splenic metastasis of endometrial adenocarcinoma. A case report and review of the literature". J. Gynecol. Obstet. Biol. Reprod., 1992, 21, 182.

[2] Berge T.: "Splenic metastasis". Acta Pathol. Microbiol. Scand., 1974, 82, 499.

[3] Cheson B.D., Bennett J.M., Grever M.: "National Cancer Institute Working Group guidelines for chronic lymphocytic leukemia Revised guidelines for diagnosis and treatment". Blood, 1996, 87, 4990.

[4] Falini B., Taylor C.R.: "New developments in immunoperoxidase techniques and their application". Arch. Pathol. Lab. Med., 1983, 107, 105.

[5] Gilks C.B., Acker B.D., Cleament P.B.: "Recurrent endometrial adenocarcinoma: Presentation as a splenic mass mimicking malignant lymphoma". Gynecol. Oneal., 1989, 33, 209.

[6] Giuliani A., Caporale A., Di Bari M., Demoro M., Mingazzini P "Isolated splenic metastasis from endometrial carcinoma". J. Exp Clin. Cancer Res., 1999, 18 (1), 93.

[7] Hamy A., Letessier E., Guitlard Y., Paineau J., Visset J.: "Splenectomy for isolated splenic metastasis from endometrial adenocarcinoma". Acta Ostet. Gynecol. Scand., 1995, 74, 745.

[8] Jorgensen L.N., Chrintz H.: "Solitary metastatic endometrial carcinoma of the spleen". Acta Obstet. Gynecol. Scand., 1988, 67 (1), 91.

[9] Klein B., Stein M., Kuten A. et. al.: "Splenomegaly and solitary spleen metastasis in solid tumors". Cancer, 1987, 60, 100.

[10] McClure J.N., Park Y.H.: "Solitary metastatic carcinoma of the spleen". South Med. J., 1975, 68, 101.

[11] Podczaski E., Kaminski P.F., Zaino R.: "CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium". Cancer, 1993, 71, 2551.

[12] Siamak A.M., Roy Y.C.: "Solitary splenic metastasis. Case report and review of the literature". Am. J. Clin. Oneal., 2001, 24 (3), 306.

Abstracted / indexed in

Web of Science (WOS) (On Hold)

Journal Citation Reports/Science Edition

Google Scholar

JournalSeek

Submission Turnaround Time

Top